[{"NetIncomeLoss_1_Q3_USD":-29765000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":28579000.0,"ContractWithCustomerAssetNetCurrent_0_Q3_USD":7215000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":15000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q3_USD":0.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_3_Q3_USD":0.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":63533000.0,"Depreciation_1_Q3_USD":1600000.0,"Depreciation_3_Q3_USD":5002000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":1823000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":260000.0,"AssetsCurrent_0_Q3_USD":302240000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-236000.0,"ContractWithCustomerLiability_0_Q3_USD":4586000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":11005229.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":11005229.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":1257000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":-10000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-122000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_0_Q3_Security":0.0,"CommonStockSharesIssued_0_Q3_shares":68934767.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":281639000.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_3_Q3_USD":2009000.0,"Assets_0_Q3_USD":326082000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":68815696.0,"ShareBasedCompensation_3_Q3_USD":11467000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":68174654.0,"GeneralAndAdministrativeExpense_3_Q3_USD":19849000.0,"ShortTermInvestments_0_Q3_USD":33973000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":123912000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":46979000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-159000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-68000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q3_USD":5455000.0,"CommonStockValue_0_Q3_USD":69000.0,"ContractWithCustomerAssetNet_0_Q3_USD":0.0,"IncreaseDecreaseInPrepaidRent_3_Q3_USD":2104000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":7926000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":573000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":94537000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":287900000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q3_USD":1267000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-74506000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-29887000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-7108000.0,"OtherAssetsNoncurrent_0_Q3_USD":6570000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":253976000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":547259000.0,"Liabilities_0_Q3_USD":49379000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-122000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"DeferredRentCreditCurrent_0_Q3_USD":2938000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":6460000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-286000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":17771098.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":8003000.0,"PaymentsToAcquireMachineryAndEquipment_3_Q3_USD":1605000.0,"CommonStockSharesOutstanding_0_Q3_shares":68934767.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"RestrictedCashNoncurrent_0_Q3_USD":1499000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":29399000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":4872000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q3_USD":5294000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":34758000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":15000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":4049000.0,"MarketableSecuritiesUnrealizedGainLoss_3_Q3_USD":0.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q3_USD":100000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-63456000.0,"LiabilitiesCurrent_0_Q3_USD":37716000.0,"AccountsPayableCurrent_0_Q3_USD":1613000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":255475000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_3_Q3_USD":1285000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":7076000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":7214000.0,"InterestBearingDepositsInBanks_0_Q3_USD":6300000.0,"NumberOfOperatingSegments_3_Q3_Segment":1.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":15773000.0,"NetIncomeLoss_3_Q3_USD":-74496000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-270640000.0,"StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_0_Q3_shares":21899.0,"DeferredRentCreditNoncurrent_0_Q3_USD":7179000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":281624000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":10.32,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":3715000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"CommonStockSharesAuthorized_0_Q3_shares":400000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":67601000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":23482000.0,"OperatingIncomeLoss_3_Q3_USD":-76160000.0,"OperatingIncomeLoss_1_Q3_USD":-29957000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_3_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":27000000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":4586000.0,"PreferredStockValue_0_Q3_USD":null,"LiabilitiesAndStockholdersEquity_0_Q3_USD":326082000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":50531000.0,"OperatingExpenses_3_Q3_USD":143761000.0,"OperatingExpenses_1_Q3_USD":53439000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":9765000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.09,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.43,"ProfitLoss_3_Q3_USD":-74496000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":4315000.0,"OperatingLeasesFutureMinimumPaymentsDueCurrent_0_Q3_USD":5141000.0,"StockholdersEquity_0_Q3_USD":276703000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":208000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q3_USD":17157000.0,"Ticker":"NGM","CIK":"1426332","name":"NGM BIOPHARMACEUTICALS INC","OfficialName":"NGM Biopharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1227500649.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20201112"}]